BPD Expands AI Services for Healthcare Leaders
BPD has announced the launch of new AI-driven services and strategic advisory offerings to support healthcare leaders in navigating industry changes.
Applications of AI in healthcare, including medical diagnostics, drug discovery, patient care solutions, and biotechnology research.
BPD has announced the launch of new AI-driven services and strategic advisory offerings to support healthcare leaders in navigating industry changes.
IBM and Inclusive Brains have entered a joint study agreement to enhance brain-machine interfaces using AI and quantum technologies, aiming to improve accessibility for individuals with disabilities.
Matterworks Inc. has announced the completion of its Series A funding round, led by Lewis & Clark Partners and OMX Ventures, to advance its machine intelligence platform for predictive biology.
Akadeum Life Sciences has closed a $20 million financing round led by Michigan Capital Network, aimed at advancing its cell separation technology for clinical trials.
ArisGlobal has announced that a sixth major pharmaceutical company will implement its LifeSphere NavaX for enhanced case processing and pharmacovigilance operations.
ArcheHealth has raised $6.7 million in seed funding to launch its AI-powered platform aimed at reducing healthcare costs and improving operational performance.
Brina Medical has launched the CMAT Advantage, a next-generation diagnostic device designed to improve chronic disease detection and patient care, announced in a press release.
Vivodyne has raised $40 million in Series A funding to expand its AI and robotics platform for drug testing, aiming to replace animal models with human tissue data.
Solera Health has launched an Enhanced AI Governance Framework to ensure responsible and transparent AI use in digital health, announced in a press release. The framework focuses on governance, privacy, and security.
Tecsys Inc. has introduced TecsysIQ, a cloud-native intelligence layer designed to enhance AI-powered insights in healthcare supply chains, as announced in a press release.
ConcertAI has launched its new Precision Suite, an AI-powered solution designed to enhance oncology insights and actions for healthcare and life sciences, announced in a press release.
ConcertAI has integrated ASCO Guidelines into its AI Precision Suite and CancerLinQ SmartLinQ solutions, enhancing oncology care recommendations. The integration, powered by CARAai, will provide guideline-concordant care recommendations to oncologists and biopharma researchers.
Transcripta Bio has announced a collaboration with Microsoft Research to enhance the discovery of disease-gene associations using AI and transcriptomic data.
Skypoint has announced the appointment of three new executives to enhance its leadership team and drive growth in healthcare AI.
Tevogen Bio Holdings Inc. has announced its new AI initiative, Tevogen.AI, in collaboration with Microsoft and Databricks to enhance immunotherapy development.
AIxMed and Lumea have announced a partnership to integrate AIxMed's AI technology into Lumea's digital pathology platform, enhancing bladder cancer diagnostics.
Illinois is on the verge of becoming the first state to regulate AI tools in mental health care with the WOPR Act, which prohibits unlicensed AI chatbots from providing therapy services.
Fresenius Medical Care presented its latest research and innovations in kidney care at the European Renal Association Congress 2025, showcasing advancements in clinical care and AI applications.
Outcomes4Me has raised $21 million to expand its AI-driven cancer care platform, with new investment from Salica Investments and existing backers like Labcorp Venture Fund.
Illumina has unveiled PromoterAI, an AI algorithm designed to identify pathogenic genetic variants in noncoding regions of the genome, enhancing rare disease diagnosis.